Pulmonx Corporation (LUNG)
NASDAQ: LUNG · IEX Real-Time Price · USD
7.28
-0.02 (-0.27%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Pulmonx Revenue

In the year 2023, Pulmonx had annual revenue of $68.68M with 27.98% growth. Revenue in the quarter ending December 31, 2023 was $19.28M with 24.98% year-over-year growth.

Revenue (ttm)
$68.68M
Revenue Growth
+27.98%
P/S Ratio
4.09
Revenue / Employee
$246,147
Employees
279
Market Cap
280.55M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202368.68M15.01M27.98%
Dec 31, 202253.66M5.25M10.84%
Dec 31, 202148.42M15.68M47.91%
Dec 31, 202032.73M138.00K0.42%
Dec 31, 201932.60M12.59M62.94%
Dec 31, 201820.00M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Akebia Therapeutics 194.62M
Sanara MedTech 64.99M
Metagenomi 44.76M
TriSalus Life Sciences 18.51M
Lyra Therapeutics 1.56M
Revenue Rankings